MA H5303

Establishes a 19-member special legislative commission to study perimenopause and menopause care, assess data on prevalence and disparities, evaluate workforce impacts, and submit findings by December 31, 2027

Requires the Department of Public Health to develop and disseminate public information on perimenopause and menopause symptoms, treatment options, and resources in multiple languages including Spanish, Portuguese, Mandarin, Cantonese, and Haitian Creole

Mandates insurance coverage for FDA-approved hormonal and non-hormonal therapies (oral, transdermal, topical, vaginal rings) to treat perimenopause and menopause across all health plans, including MassHealth, with restrictions on prior authorization and step therapy requirements

Adds perimenopause, menopause, and related medical conditions as protected classes under employment discrimination law (Chapter 151B), requiring employers to provide reasonable workplace accommodations

Requires physicians, physician assistants, and nurses serving perimenopausal/menopausal populations to complete a one-time continuing education course on diagnosis and treatment within 4 years, and designates September as Perimenopause Awareness Month and October as Menopause Awareness Month